Netflix AstraZeneca wants to buy Gilead or create largest biopharmaceutical merger
-
Last Update: 2020-06-17
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On the afternoon of June 7, AstraZeneca was in contact with Gilead Sciences about a possible merger that, if successful, would be the largest medical deal in history, involving $96 billion, according to people familiar with the matterif the merger succeeds, it will surpass the $74 billion merger between The Xerox and Newfoundation in 2019 and the $63 billion merger between AbbVie and AlKit is understood that AstraZeneca contacted Gilead last month for possible cooperationPeople familiar with the matter added that while Gilead had discussed the idea with financial advisers, it had not yet been decided and the two companies had not held formal talks
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
